← Back to Search

Nasal Guide for Dry Eye Syndrome

Phase 4

Waitlist Available

Research Sponsored by Oyster Point Pharma, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial aims to test the safety of a nasal guide when used to help deliver a nasal spray medication.

Eligible Conditions

Dry Eye Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of Adverse Events

Trial Design

1Treatment groups

Experimental Treatment

Group I: Nasal GuideExperimental Treatment1 Intervention

Use of Nasal Guide with administration of Tyrvaya (varenicline solution 0.03 mg) BID

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nasal Guide

2023

Completed Phase 4

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Oyster Point Pharma, Inc.Lead Sponsor

14 Previous Clinical Trials

1,978 Total Patients Enrolled

Marian Macsai, MDStudy DirectorOyster Point Pharma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what degree is Nasal Guide detrimental to people's health?

"Given that the Nasal Guide is in Phase 4 of development, Power rated its safety a 3 for their assessment. This signifies that this medication has been authorised and can be prescribed to patients."

Answered by AI

Are there any further opportunities to join this clinical exploration?

"Information on clinicaltrials.gov verifies that this trial is currently enrolling patients. The study was posted on June 14th 2023 and updated most recently on the 26th of that same month."

Answered by AI

How many people are being observed for this research project?

"Affirmative. Data available on clinicaltrials.gov declares that this medical study, which appeared initially on June 14th 2023, is actively recruiting for participation. Approximately 30 patients must be recruited from 2 separate medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya

2023. "Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05918406.